Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Nieuwe neuroprotectieve behandeling 2-IB veilig bij ischemische beroerte na trombectomie
dec 2025 | Neuro-vasculair